ATE401341T1 - Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis - Google Patents
Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidisInfo
- Publication number
- ATE401341T1 ATE401341T1 AT05003039T AT05003039T ATE401341T1 AT E401341 T1 ATE401341 T1 AT E401341T1 AT 05003039 T AT05003039 T AT 05003039T AT 05003039 T AT05003039 T AT 05003039T AT E401341 T1 ATE401341 T1 AT E401341T1
- Authority
- AT
- Austria
- Prior art keywords
- neisseria
- symptomatic
- proteins
- gonorrhoeae
- vaccines containing
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 101000874355 Escherichia coli (strain K12) Outer membrane protein assembly factor BamA Proteins 0.000 title abstract 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 title abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 title abstract 2
- 101000873843 Homo sapiens Sorting and assembly machinery component 50 homolog Proteins 0.000 title 1
- 102100035853 Sorting and assembly machinery component 50 homolog Human genes 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 206010018612 Gonorrhoea Diseases 0.000 abstract 1
- 208000034762 Meningococcal Infections Diseases 0.000 abstract 1
- 241001212279 Neisseriales Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98953873A EP1123403A1 (de) | 1998-10-22 | 1998-10-22 | Omp85 proteine von neisseria gonorrhoeae uand neisseria meningitidis, zusammensetzungen die sie enthalten und verfahren zur anwendung davon |
| EP9822352 | 1998-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401341T1 true ATE401341T1 (de) | 2008-08-15 |
Family
ID=39846647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05003039T ATE401341T1 (de) | 1998-10-22 | 1998-10-22 | Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1535928B1 (de) |
| AT (1) | ATE401341T1 (de) |
| CY (1) | CY1108412T1 (de) |
| ES (1) | ES2310776T3 (de) |
| PT (1) | PT1535928E (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610306B2 (en) | 1998-10-22 | 2003-08-26 | The University Of Montana | OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof |
| DE69839740D1 (de) * | 1998-10-22 | 2008-08-28 | Univ Montana | Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22302A1 (es) * | 1990-09-07 | 1995-01-31 | Cigb | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
| JP3532563B2 (ja) * | 1990-08-23 | 2004-05-31 | ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル | Ｎｅｉｓｓｅｒｉａ ｇｏｎｏｒｒｈｏｅａｅおよびＮｅｉｓｓｅｒｉａ ｍｅｎｉｎｇｉｔｉｄｉｓ由来トランスフェリン結合蛋白質 |
-
1998
- 1998-10-22 EP EP05003039A patent/EP1535928B1/de not_active Expired - Lifetime
- 1998-10-22 PT PT05003039T patent/PT1535928E/pt unknown
- 1998-10-22 ES ES05003039T patent/ES2310776T3/es not_active Expired - Lifetime
- 1998-10-22 AT AT05003039T patent/ATE401341T1/de active
-
2008
- 2008-10-14 CY CY20081101134T patent/CY1108412T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2310776T3 (es) | 2009-01-16 |
| CY1108412T1 (el) | 2014-02-12 |
| EP1535928A2 (de) | 2005-06-01 |
| EP1535928B1 (de) | 2008-07-16 |
| EP1535928A3 (de) | 2005-08-17 |
| PT1535928E (pt) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60041981D1 (de) | Neisseria meningitidis-serumgruppen b und c-antigene sowie ein zusätzliches antigen enthaltende zusammensetzungen | |
| CY1117643T1 (el) | Συνθεσεις νεϊσσεριακου εμβολιου που περιλαμβανουν συνδυασμο αντιγονων | |
| BR9910089A (pt) | Composições e antìgenos de neisseria meningitidis | |
| BR9813930A (pt) | antìgeno neisserial | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| ATE500843T1 (de) | Streptococcus pneumoniae proteine und impfstoffe | |
| DE69630457D1 (de) | Verbindungen zur immunotherapie und diagnose von tuberkulose | |
| CY1106431T1 (el) | Γονοκοκκικες πρωτεϊνες και νουκλεϊκα οξεα | |
| MA24638A1 (fr) | Vaccin | |
| ATE120093T1 (de) | Meningococcales klasse i-aussenmembranprotein- vakzin. | |
| DK1185691T3 (da) | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf | |
| ATE276758T1 (de) | Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid | |
| EP2275553A3 (de) | Antigenpeptide aus Neisseria | |
| ATE397068T1 (de) | Antigene meningokokken peptide | |
| PT1535928E (pt) | Composições de vacina compreendendo proteínas omp85 de neisseria gonorrhoeae e neisseria meningitidis | |
| ATE366583T1 (de) | Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1535928 Country of ref document: EP |